Phytochemical profiling and anti-obesity potential of the methanol extract of Carica papaya ripe fruit peel Authors: Rimsha Ahsan, Kanwal Ashiq, Shafiq Ali Shah, Muhammad Zaeem Ahsan, Shafiullah, Maryam Ashraf, Ishafaq Bukhari Published: 2026 ABSTRACT Objective: Carica papaya has been widely recognized for its medicinal benefits, particularly in treating metabolic disorders such as obesity. This study examines the weight loss effects of C. papaya fruit peel and determines its phytochemical composition.Materials and Methods: Various standard procedures were utilized for the identification and quantification of phytochemicals. UV/Vis spectroscopy, Fourier Transform Infrared Spectroscopy (FTIR) and Gas Chromatography–Mass Spectrometry (GC/MS) were utilized to identify the functional groups and volatile compounds. In vitro, pancreatic lipase inhibition assay and in vivo, high-fat diet rat model were used to evaluate the anti-obesity activity of the methanol extract. Lipid profile, liver function tests (LFTs) and renal function tests (RFTs) were measured, and histopathological studies of the pancreas, liver, and kidneys were performed.Results: The results of phytochemical analysis revealed the presence of various compounds such as flavonoids, polyphenols, and glycosaponins which are recognized for their anti-obesity properties. GC/mass analysis also confirmed the existence of volatile compounds. The methanol extract from C. papaya fruit peel significantly inhibited pancreatic lipase activity dose-dependently. In vivo studies showed that the methanol extract reduced the weight, improved the lipid profile, and restored the normal structure of the pancreas, liver, and kidneys. These effects were nearly identical to those of the standard reference drug, orlistat.Conclusion: This study confirms the anti-obesity activity of C. papaya fruit peel. Further clinical studies are needed to validate its safety and efficacy, as well as to explore its underlying mechanisms of action. Introduction Obesity is a complex, multifactorial disease that arises due to an imbalance between energy intake and expenditure and is caused by genetic, environmental, and hormonal factors. It affects males and females of all ages and ethnicities in various locations. The morbidity and mortality have significantly increased around the globe, especially in individuals with comorbid conditions like diabetes, coronary heart disease, cancer, atherosclerosis, and hypertension (Kokkorakis et al. 2024). According to the World Health Organization (WHO), the condition of overweight or obesity results from the excessive or abnormal deposition of fats in body tissue, which directly threatens well-being. The general body fitness is measured by a simple matrix called the body mass index (BMI). In addition, increased BMI is associated with many health problems resulting in deteriorating quality of life (QoL) (Hasani-Ranjbar et al. 2013; Hall et al. 2022). Because obesity is linked to ill health and, therefore, costly medical treatment, it has to be the primary focus of cost-containment initiatives. To allow physicians to control obesity effectively, there has to be a rigorous evaluation of the patient's health factors influencing metabolism, energy intake, and expenditure (Ludwig et al. 2022; Westbury et al. 2023; Bakinowska et al. 2024). Current treatments for obesity include lifestyle modifications, pharmacotherapy, and surgical interventions. The first-line approach continues to be dietary changes, increased physical activity, and behavioral therapy. Pharmacological options include glucagon-like peptide-1(GLP-1) receptor agonists like semaglutide and appetite suppressors like orlistat, notably impacting weight loss. Bariatric surgery, including gastric bypass and sleeve gastrectomy, is reserved for those with severe obesity and is effective in the long term for weight loss and metabolic health. Upcoming therapies include gut microbiota modulation, gene-based treatments, and new drugs targeting fatness-related energy expenditure pathways. Such innovative approaches seek to improve long-term weight management and mitigate obesity-related complications (Cornier 2022). There is a new shift in the attitude of the public towards the health consequences of obesity and the social pressure to be thin and be satisfied with one's body. More research must be conducted to identify successful behavioral change strategies to be translated and applied to diverse groups (Blumberg 2024). Further research is also needed to develop safer and more effective drugs that will help obese people lose weight and maintain it in the long run. Medicinal plants may provide a less expensive and safer method of treating obesity. Many medicinal plants have been used traditionally for weight management (Ashiq et al. 2021; Nabi et al. 2023; Salehsari et al. 2024). Humans have been utilizing plants for thousands of years for many purposes. Plants are crucial since they comprise over 250,000 species and contain metabolites that have pharmacological activities (Süntar 2020; Batool et al. 2024). There has been global research to verify their efficacy, and some findings have led to the development of plant-based drugs. The WHO reports that developing countries use naturally occurring substances for medical purposes. However, most countries rely mainly on plant-based medicine (Latif et al. 2020). Considering medicinal plants' relevance in managing and treating various disorders, the current paper shall focus on Carica papaya. Carica papaya, often called papaya or pawpaw, is a fruit-bearing plant from the Caricaceae family, originating in Central America. Today, it is extensively grown in tropical and subtropical areas worldwide. Papaya is highly valued for its nutritional benefits, offering a rich supply of vitamins such as vitamin C, vitamin A, and folate, along with essential enzymes like papain which plays a vital role in digestion. Additionally, various parts of the papaya tree including its leaves, seeds, and fruit skin, have been utilized in traditional medicine for their therapeutic properties, particularly in addressing infections, digestive problems, obesity, diabetes, dengue, malaria, inflammation, hypertension, and skin conditions. Furthermore, the papaya fruit contains different valuable phytochemicals including alkaloids, saponin, glycosides, ferulic acid, caffeic acid, flavonoids, polyphenols, carpine, and papain. It also has a range of vitamins, such as A, C, E, and B complexes (Ugbogu et al. 2023; Babalola et al. 2024). Carica papaya has also come under the spotlight for its ability to control metabolic diseases such as obesity, since its high fibre level and enzyme activity are thought to aid digestion and facilitate weight maintenance. Studies indicate the plant's metabolites may regulate metabolic processes and lower fat storage in the body. Despite its historical applications and new scientific justification, additional investigation is necessary to fully understand its mechanisms of action and therapeutic effects, especially for its use in obesity and obesity-related metabolic disorders (Od-Ek et al. 2020). In traditional medicine, the plant's fruit and leaf juice is often used to treat obesity problems. Until now, various experiments have been conducted on seeds, leaves, and fruits to prove their beneficial effect in reducing body weight and treating obesity-related issues. Papaya peels can be another promising agent in weight loss that needs further investigation. Thus, it is crucial to validate the anti-obesity properties of C. papaya fruit peels through well-designed scientific experiments (Matsuane et al. 2023; Ugbogu et al. 2023). Therefore, the present study is an initial study investigating ripened C. papaya fruit peel's phytochemical constituents and anti-obesity effects. Materials and Methods Chemicals Quercetin, Acetic anhydride, Bovine serum albumin (BSA), Folin-Ciocalteu (FC) reagent, Carboxy methyl cellulose (CMC), Glucose, Aluminum chloride (AlCl₃), Sodium hydroxide (NaOH), Ethanol, n-Hexane, Chloroform, Sulfuric acid (H₂SO₄), Methanol, Gallic acid and Pancreatic lipase are some of the reagents employed in the process of the work and were acquired from Sigma and Merck. Carica papaya fruit collection, authentication, and drying Carica papaya ripened fruit was collected from the local market of Lahore, Pakistan. The plant was identified by Prof. Dr Zaheer, botany faculty, Government College University (GCU), Lahore, Pakistan, under voucher 4056. The peels from the ripe fruit were separated and dried under share for 25 days. After drying the peels, they were ground into powder Extraction, drying and storage of the extracts The C. papaya fruit peel powder was extracted in methanol using the maceration method. The powder was macerated in methanol for seven days. During maceration, the powder was often shaken. After seven days, it was filtered, and the solvent was evaporated using a rotary evaporator. Then, the extract was stored in a clean, dried and labelled vial at 4°C. Qualitative and quantitative assessment of the phytochemicals Qualitative analysis was done based on the established methods. Quantitative estimation of primary metabolites (protein, carbohydrates and lipids) (Lowry et al. 1951; Shahidi and Wanasundara 2002; Yemm and Willis 1954) and secondary metabolites (flavonoids, glycosaponins and polyphenols) (Arvouet-Grand et al. 1994; Siddiqui et al. 2009; Singleton and Rossi 1965) was carried out based on published procedures. Analytical studies Fourier Transform Infrared Spectroscopy (FTIR) profiling FTIR (Agilent, USA) scans of C. papaya fruit peel were taken by taking a minute quantity of the powder. UV/Vis scanning The diluted solution of the extract (1 mg/ml) was prepared in methanol. Then, the solution was scanned from 200 nm to 800 nm for UV/Vis profiling. Gas Chromatography–Mass Spectrometry (GC/Mass) analysis For analysis, the GCMS-QP2010 (Shimadzu, Tokyo, Japan) system was used. It set the injection temperature at 200°C, making possible injectable-type introduction with a split ratio. The sample was introduced to the column in the split mode at 0°C. The flow control mode was controlled through pressure regulation that maintained system pressure within 100 kPa. At a column flow of 1.69 ml/min, an overall flow rate of 165.04 ml/min was used so that the flow was perfectly in control and there was complete passage of analytes through the column. A 47.2 cm/sec linear velocity was established for the best possible separation efficiency. The ion source temperature was maintained at 200°C, and the GC and MS interface temperature was set to 250°C; it would take about three minutes in solvent cut time to avoid interference from the solvent peak. The results were interpreted using the NIST library. In vitro studies Pancreatic lipase inhibition assay The protocol followed was already published. Briefly, dimethyl sulfoxide (DMSO) was used to dissolve the extract at a concentration of 1 mg/ml. Pancreatic lipase (50 μl) and reaction buffer (30 μl), along with either extract or standard solution at 1 mg/ml, were mixed together, and this mixture was continuously shaken and incubated at 37°C for 10 min. To initiate the enzymatic reaction, 100 μl of 1 mM 4-nitrophenyl phosphate (4-NPP) was added as a substrate. The appearance of a yellow color indicated the formation of 4-nitrophenol (4-NP), a product of substrate hydrolysis. Orlistat was selected as the standard reference drug for comparison. The experiment was done in triplicates, and absorbance was measured at 405 nm (Bae and Kim 2011; Stoytcheva et al. 2012). Percentage inhibition was calculated using the following formula: % inhibtion=Abs of enzyme-Abs of theextractabsof enzymex100 In vivo studies Animal housing and diet This work used male Sprague-Dawley rats with an age range of 4–5 weeks, body weights ranging from 150 to 200 g, and kept them in housing facilities at 22°C ± 2°C under controlled humidity, 40%–60% and controlled photoperiod for 12 ± 1 hr. Animals received free access to food and water. The high-fat diet (HFD) formulation contained 29.5 g of beef tallow, 22.0 g of casein, 23.0 g of starch, 17.9 g of cellulose, 4.0 g of L-cysteine, 0.3 g of choline chloride, 11.8 g of a vitamin mixture, and 10.5 g of a mineral mixture. Ethical approval The study obtained ethical clearance from the Research and Ethics Committee of Superior University, Lahore, Pakistan (Reference number: SU/FoP/MSPCW/F22-06). Experiment After one week of accommodation, the rats were assigned random numbers. Apart from the normal control group, rats were fed an HFD for 4 weeks. The rats fed on HFD were found to have a visible increase in body fat after four weeks compared to the rats fed on a regular diet, thereby initiating the treatment protocol. The extract or the positive control orlistat was administered orally five times a week by gavage in a solution containing 0.5% CMC for eight weeks. Normal control group rats were provided with an equal volume of 0.5% CMC. Their food intake and body weight were observed thrice a week. Before sacrifice, all the animals involved in the experiment were starved for the whole night. Animals were euthanized under deep anesthesia induced by intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg), and their organs -liver, kidney, and pancreas- were histologically examined after taking blood samples from all the animals (Lim et al. 2013; Lee et al. 2018). The summary of each animal group (n=6) is as follows: Group I (normal control group): Received standard diet only. Group II (disease group): Rats were fed on a high-fat diet (HFD) to induce disease. Group III (CPRFM/treatment group): Obese rats, induced by HFD were orally administered a 500 mg/kg dose of methanol extract of Carica papaya fruit peel (CPRFM) daily for 14 days. Group IV (standard group): Standard treatment with orlistat (10 mg/kg) was administered orally once daily for 14 days following HFD-induced obesity. Statistical analysis Statistical analysis was conducted with GraphPad Prism and Microsoft Excel. A regression analysis of phytochemicals was utilized with an in vitro study expressed as mean ± standard deviation (SD). The mean of data collected in an in vivo study used a one-way ANOVA coupled with post hoc Tukey's test to derivate the SEM. P-values less than 0.05 were considered statistically significant. Results Qualitative and quantitative assessment of the phytochemicals The qualitative analysis of the phytochemicals was carried out using various established protocols. Any color change during the reaction was noted. The results of the qualitative analysis are presented in Table 1. Table 1Qualitative assessment of phytochemicals in methanol extract of Carica papaya fruit peel Test Methanol extract Proteins++Lipids+Carbohydrates+++Flavonoids+++Polyphenols+++Saponins+++ = weak reaction, ++ = moderate reaction, +++ = intense reaction Qualitative assessment of phytochemicals in methanol extract of Carica papaya fruit peel + = weak reaction, ++ = moderate reaction, +++ = intense reaction The results indicated the presence of proteins, carbohydrates, and lipids in the methanol extract, which means its nutritional value. In addition, the presence of polyphenols and flavonoids suggests the plant's medicinal value. The results of the estimation of primary metabolites are represented in Table 2. The content of total proteins was estimated through the BSA standard curve having y = 0.0005x + 0.015 and R² = 0.9794. The estimation of carbohydrates was done through a glucose calibration curve with y = 0.0003x + 0.0138 and R² = 0.9897. The estimation of primary metabolites proved the existence of carbohydrates (467±0.045 mg/g), proteins (106.55±0.076 mg/g) and lipids (45.79±0.095 mg/g), which proved to be rich in nutritional contents. The results of the estimation of primary metabolites are represented in Table 3. Total polyphenol contents were determined based on the gallic acid standard curve: y = 0.0028x + 0.0082 R² = 0.9832. The total flavonoid contents were determined using a quercetin calibration curve with y = 0.0023x + 0.0092 and R² = 0.9869. All standard curves are provided in Supplementary File 1. The results of the present study established the existence of essential secondary metabolites, such as polyphenols (167.71±0.096 µg/g), flavonoids (156.29±0.071 µg/g) and glycosaponins (109.34±0.083 µg/g). FTIR profiling Figure 1 is the FTIR spectrum scan showing peaks corresponding to different functional groups. A strong, broad peak at 3310 cm⁻¹ corresponds to the O–H stretching vibrations indicative of hydroxyl groups overlapping with N–H stretching by amines or amides. Peaks from 2920 to 2850 cm⁻¹ signify C–H stretching of aliphatic –CH₂ and –CH₃ groups. A broad absorption at 1760 cm⁻¹ corresponds to C=O stretching, which is commonly found in esters or carboxylic acids. The band at 1610 cm⁻¹ is due to C=C stretching vibrations of aromatic rings or alkenes. Other peaks between 1400–1460 cm⁻¹ correspond to C–H bending and bands between 1200–1300 cm⁻¹ and 1000–1100 cm⁻¹ correspond to C–O and C–O–C stretching, respectively, indicating the presence of alcohols, esters, ethers, or polysaccharides. The fingerprint area of 600–900 cm⁻¹ displays out-of-plane C–H bending motions characteristic of aromatic compounds. UV/Vis scanning For the UV/Vis spectroscopy profiling of the papaya ripe fruit peel's methanol extract, the result is as presented in Figure 2. The four major peaks recorded in the scan were 505.05 nm (peak 1), 267.90 nm (peak 2), 260.50 nm (peak 3) and 226.90 nm (peak 4). GC/Mass analysis The results for GC/Mass spectroscopy are shown in Figure 3. The observations indicated the availability of some of the valuable compounds such as 2-Pentanone, 4-hydroxy-4-methyl, diacetone alcohol, docosanoic acid, octadecanoic acid, Oxirane, -epoxy tetradecane, 11,14-eicosadienoic acid and 1,2-benzenedicarboxylic acid (Table 4). Table 2Quantitative estimation of primary metabolites in methanol extract of Carica papaya fruit peel (mean ± SD, mg/g dry weight) Sample Total proteins Total carbohydrates Total lipids Methanol extract of Carica papaya ripe fruit peel106.55±0.076467±0.04545.79±0.095 Quantitative estimation of primary metabolites in methanol extract of Carica papaya fruit peel (mean ± SD, mg/g dry weight) Table 3Quantitative estimation of primary metabolites in methanol extract of Carica papaya fruit peel (mean ± SD, µg/g dry weight) Sample Total polyphenols Total flavonoids Glycosaponins Methanol extract of Carica papaya ripe fruit peel 167.71±0.096156.29±0.071109.34±0.083 Quantitative estimation of primary metabolites in methanol extract of Carica papaya fruit peel (mean ± SD, µg/g dry weight) Table 4Identification of compounds in methanol extract of Carica papaya fruit peel using GC/Mass Compound Retention Time Area % Molecular formula 2-Pentanone, 4-hydroxy-4-methyl, diacetone alcohol3.1189.19C6H12O2Docosanoic acid3.475.29C22H44O2Octadecanoic acid14.633.03C18H36O2Phytol15.3751.87C20H40OEicosadienoic acid 15.6812.38C20H36O21,2-benzene dicarboxylic acids17.8378.25C8H6O4 Identification of compounds in methanol extract of Carica papaya fruit peel using GC/Mass FTIR spectra of Carica papaya fruit peel powder UV/Vis profiling of methanol extract of Carica papaya fruit peel GC/Mass spectra of methanol extract of Carica papaya fruit peel In vitro studies Pancreatic lipase inhibition assay Figure 4 illustrates the results of the pancreatic lipase inhibition assay. The extract and standard drug were evaluated at various doses to determine their ability to inhibit pancreatic enzyme pancreatic enzyme activity. According to the study findings, the extract and orlistat had a concentration-dependent effect. The IC50 of the methanol extract was found to be 510.48 μg/ml, and the IC50 of orlistat was estimated to be 440.70 μg/ml. Lipase inhibition assay In vivo studies Weight change The results of the body weight changes are presented in Figure 5. The change in the study's results between the normal group and the disease group shows weight change is also different in these two groups by day 3 to day 14 at (p<0.05). However, extract and orlistat (standard) had a highly significant weight reduction compared to the disease group. They showed insignificant results compared to the control group from day 10 to day 14 (p>0.05). Biochemical parameters The results of lipid profile, liver function tests (LFTs) and renal function tests (RFTs) are summarized in Tables 5-7. The findings illustrated that the methanol extract significantly improved the lipid profile, LFTs, and RFTs. Concentration-dependent response of methanol extract of Carica papaya fruit peel and standard drug (orlistat) using pancreatic lipase assay Change in weight after in vivo administration of methanol extract of Carica papaya fruit peel (CPRFM) and standard drug (orlistat) using high-fat diet-induced obesity rats. *Disease group compared to normal group, #treatment and standard groups compared to disease group. * and #p<0.05, ** and ##p<0.01, and *** and ### p<0.001, Table 5 Effect of methanol extract of Carica papaya fruit peel on lipid profile in rats with high-fat diet-induced obesity Group Total lipids (mg/dl) Cholesterol (mg/dl) TGs (mg/dl) HDL cholesterol (mg/dl) LDL cholesterol (mg/dl) VLDL cholesterol (mg/dl) Control 230±0.6767±0.3285±0.5627±0.6863±0.4716±0.43Disease 267±0.04***85±0.48**90±0.31*33±0.29*80±0.36***25±0.55**Standard230±0.10###72±0.09##81±0.34#28±0.53##65±0.07###19±0.31##CPRFM(500 mg/kg)218±0.07###72±0.71##84±0.67#30±0.11#65±0.57###17±0.37###*Disease group compared to normal group, #methanol extract of Carica papaya fruit peel (CPRFM) and orlistat (standard) groups compared to disease group, * and # p<0.05, ** and ##p<0.01 , and *** and ### p<0.001. Triglycerides (TGs), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) Effect of methanol extract of Carica papaya fruit peel on lipid profile in rats with high-fat diet-induced obesity *Disease group compared to normal group, #methanol extract of Carica papaya fruit peel (CPRFM) and orlistat (standard) groups compared to disease group, * and # p<0.05, ** and ##p<0.01 , and *** and ### p<0.001. Triglycerides (TGs), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) Table 6 Effect of methanol extract of Carica papaya fruit peel on liver function tests (LFTs) in rats with high-fat diet-induced obesity Group Total bilirubin (mg/dl) Direct bilirubin (mg/dl) Indirect bilirubin (mg/dl) ALT U/L AST U/L ALP U/L Total proteins g/dl Albumin g/dl Globulin g/dl Control 0.64±0.230.32±0.280.32±0.0750±0.6160±0.4390±0.356.62±0.254.62±0.052.00±0.11Disease 0.70±0.08*0.34±0.460.36±0.54*65±0.06**109±0.48**157±0.41***7.24±0.66*4.62±0.053.10±0.29**Standard 0.64±0.16#0.33±0.370.31±0.42#32±0.41###57±0.71###86±0.29###6.15±0.59##4.10±0.392.15±0.76##CPRFM (500 mg/kg)0.68±0.15#0.32±0.320.38±0.3256±0.65###85±0.05###127±0.27###6.85±0.71##4.33±0.482.52±0.28## *Disease group compared to normal group, #methanol extract of Carica papaya fruit peel (CPRFM) and orlistat (standard) groups compared to disease group. *, #p<0.05, **, ##p<0.01, and ***, ###p<0.001. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) Effect of methanol extract of Carica papaya fruit peel on liver function tests (LFTs) in rats with high-fat diet-induced obesity *Disease group compared to normal group, #methanol extract of Carica papaya fruit peel (CPRFM) and orlistat (standard) groups compared to disease group. *, #p<0.05, **, ##p<0.01, and ***, ###p<0.001. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) Table 7Effect of methanol extract of Carica papaya fruit peel on renal function tests (RFTs) in rats with high-fat diet-induced obesity Group Urea (mg/dl) BUN (mg/dl) Creatinine (umol/L) Control 21.00±0.5410.59±0.3253.00±0.16Disease 32.00±0.44**14.50±0.52*75.00±0.41***Standard18.60±0.39###9.30±0.17##54.00±0.67###CPRFM (500 mg/kg)24.80±0.27##12.40±0.41#55.00±0.58###*Disease group compared to normal group, # methanol extract of Carica papaya fruit peel (CPRFM) and orlistat (standard) groups compared to disease group. *, #p<0.05, **, ##p<0.01, and ***, ###p<0.001. Blood urea nitrogen (BUN) Effect of methanol extract of Carica papaya fruit peel on renal function tests (RFTs) in rats with high-fat diet-induced obesity *Disease group compared to normal group, # methanol extract of Carica papaya fruit peel (CPRFM) and orlistat (standard) groups compared to disease group. *, #p<0.05, **, ##p<0.01, and ***, ###p<0.001. Blood urea nitrogen (BUN) Histopathological findings The histopathological findings of the pancreas, liver, and kidneys are shown in Figures 6-8. The tissue morphology was studied at 10x magnification using Hematoxylin and Eosin (H and E) staining. The study demonstrated significant differences among the untreated control, disease, standard, and C. papaya fruit peel extract-treated groups. The pancreas of the disease group showed islet hyperplasia, increased inflammation, and oxidative stress markers that compromised insulin secretion. On the other hand, the control group had normal architecture of the pancreas, characterized by well-defined islets and healthy acinar cells. The standard treatment group showed significant protection with preserved islet integrity and reduced inflammation. The extract-treated group partially restored the pancreatic structure and improved β-cell function, showing moderate protection. The liver of the disease group showed severe steatosis, ballooning degeneration, and inflammatory infiltrates, indicating progression toward non-alcoholic fatty liver disease (NAFLD). However, the control group remained consistent in its hepatic structure without damaging hepatocytes. Both extract and standard treatment groups showed minimal steatosis and intact liver architecture, indicating protection against obesity-induced liver damage. The kidneys of the disease group presented with glomerulosclerosis, tubular atrophy, and interstitial inflammation, which characterize obesity-related renal impairment. On the other hand, the control group showed normal morphology of the glomeruli and intact tubular epithelium. In the extract-treated group, there was marked preservation of tubular integrity and architecture of the glomeruli, indicating a protective activity against obesity-related kidney damage. Similarly, the standard treatment improved renal morphology by reducing the damage to the glomeruli, strengthening its therapeutic action. Effect of methanol extract of Carica papaya fruit peel on the pancreas histology in rats with high-fat diet-induced obesity (10x). Control group – Normal pancreatic architecture with well-preserved islets of Langerhans (indicated by the box), Disease group – Disruption of normal architecture and reduced islet density after HFD administration, Standard group (Orlistat 10 mg/kg) – Partial restoration of pancreatic structure with moderately preserved islets and Treatment group (methanol extract of Carica papaya fruit peel 500 mg/kg) – Improved architecture with visible islet regeneration, though less compact than the control. Effect of methanol extract of Carica papaya fruit peel on the liver histology in rats with high-fat diet-induced obesity (10x). The control group exhibited normal hepatic architecture with polygonal hepatocytes radiating around a central vein, indicating a well-preserved lobular structure. The disease group showed disrupted liver architecture with distorted polygonal shapes, hepatocellular degeneration, and dilated sinusoids following HFD administration. The standard group (Orlistat 10 mg/kg) demonstrated partial restoration of hepatic structure, with moderately preserved polygonal hepatocytes and improved cellular alignment. The treatment group (methanol extract of Carica papaya fruit peel 500 mg/kg) displayed improved liver architecture with regenerating polygonal hepatocytes and a more defined central vein region, though still less organized than the control as indicated by triangle. Effect of methanol extract of Carica papaya fruit peel on the kidney histology in rats with high-fat diet-induced obesity (10x). The control group displayed normal renal architecture with clearly defined glomeruli and intact Bowman’s capsules, surrounded by uniform renal tubules. In the disease group, there was evident glomerular shrinkage (triangle) and tubular dilation (circle), along with disrupted tissue organization and inflammatory infiltration, indicating damage (box) due to HFD administration. The standard group (Orlistat 10 mg/kg) showed partial recovery with restored glomerular structures (triangle) and reduced tubular vacuolization. In the treatment group (methanol extract of Carica papaya fruit peel 500 mg/kg), noticeable improvement was observed, with glomerular regeneration (box) and relatively preserved tubules (circle), although the structure was still less compact compared to the control. Discussion Obesity, defined as an excessive accumulation of body fat, is a worldwide health disorder leading to chronic diseases like type 2 diabetes, cardiovascular disease, and cancer. Its multifactorial aetiology encompasses physiological, behavioral, environmental, and genetic components (Elmaleh-Sachs et al. 2023). Its management involves behavioral therapy, dietary modification, exercise, and occasionally medication or surgery. Yet, nature-based alternatives such as medicinal plants are increasingly researched owing to fears of the side effects and expenses of drug treatments (Blüher et al. 2023). Traditional medicine has long employed medicinal plants. Their bioactive compounds may modulate metabolic pathways, decrease fat absorption, improve fat metabolism, and inhibit appetite. Most medicinal plants possess alkaloids, saponins, flavonoids, and polyphenols, which have shown anti-obesity effects (Talib et al. 2020; Nyangono et al. 2022). Medicinal plants have fewer side effects compared to synthetic medicines and offer a more holistic method of treating obesity. Standardization of dosage, safety, and efficacy are, however, issues. Whereas the evidence supports their anti-obesity effects, clinical trials need to verify long-term efficacy and modes of action (Munir et al. 2022; Sun and Shahrajabian 2023). Carica papaya or papaya contains many bioactive constituents providing diverse therapeutic properties like better digestion, minimized inflammation, and antioxidant effects as a result of excessive levels of vitamins A and C. Its medicinal properties make it a desirable dietary ingredient and a promising drug discovery candidate (Ugbogu et al. 2023; Babalola et al. 2024). Carica papaya is of great potential in anti-obesity treatment. Its high fibre and low-calorie content increase satiety and reduce calorie consumption, making it useful in weight control. Its antioxidants and anti-inflammatory substances can also inhibit obesity-induced chronic inflammation. Papain, a papaya enzyme, aids digestion, metabolism, and further control of obesity. Papaya has been found to regulate blood glucose and improve fat metabolism, possibly enhancing its purpose in weight regulation (Od-Ek et al. 2020). The methanol extract from the peel of ripe C. papaya fruit was found to be rich in bioactive phytochemicals, including polyphenols, flavonoids, and glycosaponins. The polyphenol content indicated significant antioxidant activity. Polyphenols are known to influence lipid metabolism, reduce oxidative stress, and affect energy balance, making them relevant for obesity prevention and treatment. Similarly, the extract contained a high concentration of flavonoids, which are associated with anti-obesity effects through mechanisms such as inhibiting adipogenesis, enhancing lipid breakdown, and modulation of glucose uptake. Glycosaponins have been reported to curb appetite, inhibit pancreatic lipase activity, and reduce lipid absorption in the intestines, contributing to their anti-obesity effects. The abundance of these phytochemicals in ripened C. papaya fruit peel suggests their potential as natural remedies for obesity and related metabolic disorders. Further in vivo studies and clinical trials are needed to validate these effects and to explore their mechanisms in more detail (Martial-Didier et al. 2017; Od-Ek et al. 2020; Munir et al. 2022). Additionally, the FTIR spectrum of the methanol extract showed several characteristic absorption peaks linked to various functional groups, confirming the presence of phytochemicals, such as polyphenols, flavonoids, terpenoids, and tannins. GC/mass spectroscopy of the methanol extract of the ripened C. papaya fruit peel identified several bioactive molecules. Among them are 2-pentanone, 4-hydroxy-4-methyl (diacetone alcohol), used as a solvent and antimicrobial agent, and phytol, a diterpene with antioxidant and lipid-lowering properties. Long-chain fatty acids such as docosanoic acid, octadecanoic acid, and eicosadienoic acid which are involved in lipid metabolism and energy regulation, were also identified. The presence of 1,2-benzene dicarboxylic acids suggests their potential antioxidant and metabolic-modulating activities. These compounds contribute to the extract's potential effectiveness in managing obesity (Wrzosek et al. 2022; Yan et al. 2022). The study demonstrated that papaya peel extract can inhibit pancreatic lipase activity, suggesting a potential mechanism for reducing fat absorption to manage obesity. Reducing fat absorption is crucial for weight control and promoting metabolic health (Rajan et al. 2020). This research supports the anti-obesity effectiveness of C. papaya ripe fruit peel, as evidenced by an in vivo rat study. After treatment with papaya peel extract, the groups receiving the extract exhibited significant reductions in body weight, fat accumulation, and serum lipid levels. A previous study found that papaya juice could inhibit pancreatic lipase activity, restore normal organ histology, elevate serum superoxide dismutase levels, and lower serum cytokine (interleukin 6) levels (Od-Ek et al. 2020). Another study showed similar results with ethanol extract of papaya leaf (Shaikh et al. 2025). The current findings align with earlier research indicating that plants rich in flavonoids and polyphenols enhance metabolic health (Saad 2023; Mohebbati et al. 2024). The study underscores the potential of incorporating papaya peels into weight loss programs and emphasizes the need for further research to evaluate their long-term effects and feasibility as a functional food product (Asyifah et al. 2014). This research, however, is not without limitations. The small size of the rat sample might have implications for statistical power and result generalizability. The study period could be too short to establish the long-term impact of papaya peel extract on obesity. Fluctuations in flavonoid and polyphenol levels could have affected results. Although improvements in lipid profile and body weight were noted, the biochemical pathways are unknown, and extrapolation from animals to human beings is unclear. Clinical trials are thus warranted to establish safety and efficacy in human subjects. In conclusion, the C. papaya fruit peel extract exhibited therapeutic potential in an anti-obesity model, as demonstrated by the pancreatic lipase assay and the high-fat diet model. The extract improved organ function, reduced inflammation, and provided protection against obesity-related damage. Further in vivo studies and clinical trials should be conducted to analyze its long-term efficacy and underlying mechanisms, which may lead to the development of novel anti-obesity therapies.